Hypothyroidism Clinical Trial
Official title:
A Multicenter, Randomized, Double-blind, Dose-conversion Study to Evaluate the Safety and Efficacy of Hormone Replacement Therapy With Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants Who Are Euthyroid on T4 Replacement Therapy
This study will evaluate the safe and effective dose conversion from levothyroxine (synthetic T4) therapy to Armour Thyroid therapy in participants who are on a stable dose of levothyroxine and have thyroid stimulating hormone (TSH) levels within the normal reference range.
This study will include will include a Screening Period, double-blinded Titration Period (at least 18 weeks, up to 36 weeks), and a double-blinded Stabilization Period (12 weeks). Participants will be randomized to receive either their same dose of levothyroxine or an approximately, matching dose of Armour Thyroid, using a dose-conversion chart based on the United States Pharmacopeia (USP) Drug Information 2000, which states that 1 grain of Armour Thyroid is equivalent to 100 mcg of levothyroxine. During the Titration Period, Investigators will have the option to up-or down-titrate a participant's dose as needed based on the participant's TSH level (normal reference range 0.45 - 4.12 mIU/L, inclusive). At Week 18, if a participant's TSH levels are not within the normal reference range, the Investigator may up-or down-titrate the dose by continuing the Titration Period beyond Week 18 for up to a maximum of 3 additional titrations at 6-week intervals. Participants whose TSH levels have not normalized after the maximum 3 additional titrations will not enter the Stabilization Period. At the end of the Titration Period, participants with TSH levels within normal reference range may enter the Stabilization Period. Depending on whether a participant requires additional dose titration after the Week 18 visit, the Stabilization Period may end at Week 30, 36, 42, or 48. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05975866 -
The Effects of an Anti-inflammatory Diet With or Without Curcumin Supplementation on Anthropometric Measurements, Concentrations of Thyroid Hormones, Anti-TPO, and Systemic Inflammation in Plasma and NFK-B in Peripheral Blood Mononuclear Cells in Patients With Hashimato
|
N/A | |
Not yet recruiting |
NCT05334771 -
Early Detection of Endolymphatic Hydrops in Hypothyroid Patients
|
||
Withdrawn |
NCT01707056 -
The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
|
N/A | |
Completed |
NCT00094237 -
Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke
|
N/A | |
Recruiting |
NCT06015620 -
Comorbidities Resolution After MGB Surgery and Change in Body Composition
|
||
Completed |
NCT03612908 -
TSHβX1 and D2 THR92ALA in Pregnancy
|
||
Completed |
NCT04782856 -
Energy Metabolism in Thyroidectomized Patients
|
Phase 2 | |
Completed |
NCT01921452 -
Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit
|
Phase 4 | |
Completed |
NCT01197183 -
Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France
|
N/A | |
Recruiting |
NCT05247476 -
Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.
|
Phase 4 | |
Recruiting |
NCT03754621 -
Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey
|
||
Completed |
NCT02959827 -
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
|
||
Withdrawn |
NCT02577367 -
Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding
|
Phase 4 | |
Completed |
NCT04098991 -
Improving White Matter Integrity With Thyroid Hormone
|
||
Not yet recruiting |
NCT03257566 -
Hypothyroidism in Patients With Type 1 Diabetes
|
N/A | |
Terminated |
NCT02567877 -
Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?
|
||
Completed |
NCT02280330 -
Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months
|
Phase 4 | |
Completed |
NCT00403390 -
Generic vs. Name-Brand Levothyroxine
|
N/A | |
Not yet recruiting |
NCT06096454 -
Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance
|
Phase 4 | |
Completed |
NCT04528225 -
A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer
|